Our Products
Weihai Lotus currently has two products in the market, Galake® (containing dihydrocodeine and paracetamol) and Lutilium® (containing domperidone). Both products are formulated, tableted and packaged in Weihai and the Company is developing additional novel generic products in its Development Laboratories and in collaboration with partners in China and internationally. The new products will be successfully registered and brought to market in the coming years.
K5hfbtprw1vgehwgjjzg
Our Products
Weihai Lotus currently has two products in the market, Galake® (containing dihydrocodeine and paracetamol) and Lutilium® (containing domperidone). Both products are formulated, tableted and packaged in Weihai and the Company is developing additional novel generic products in its Development Laboratories and in collaboration with partners in China and internationally. The new products will be successfully registered and brought to market in the coming years.
Lutilium®
Domperidone 10mg
Uamykihlc0hu6qnjk8fs

Domperidone, Lutilium®, in the general category of gastro kinetics, is used for nausea, vomiting and for functional digestive complaints such as dyspepsia. Weihai Lotus manufacture of Lutilium® includes the complete formulation from the active drug substance, processing into tablet form, blistering and packaging. Lutilium® was licenced by the Chinese authorities as the first generic version of the original product.



Galake®
Dihydrocodeine 10mg & Paracetamol 500mg
Wvo1jeykiqierkxgnq0p

Galake® was first introduced into China by Lotus Healthcare in 1996, it has for many years been in wide use in the United Kingdom and is indicated for the treatment of a wide range of painful conditions. Galake® is used for pain management due to trauma, surgical and gynaecological operations, moderate pain due to first stage cancer, muscular pain such as lumbago, fibrosis and back pain, headache, toothache, dysmenorrhea and other persistent pain caused by strains, sprains and sinusitis. It is also indicated for severe cough, particularly non-inflammatory coughs; and the symptoms of headache, fever and cough caused by the common cold.



SMR-Rhotard®
Sustained release morphine sulphate tablets
A6cjctuezqbxza9bi4xf

SRM-Rhotard®, a 12 hour sustained release morphine sulphate tablet, was first introduced into China in 1996 by Lotus Healthcare. It was first manufactured in Lianyungang Lotus, a Lotus Joint Venture with Chinese partners. Lotus has divested the assets of the Joint Venture to the Chinese partners and is in the process of reregistering the site of manufacture of SRM-Rhotard® to Weihai Lotus. SRM-Rhotard® is in comparative clinical testing and is expected to regain marketing approval from the changed manufacturing location in 2019.



Iqcxolpj2y6cjpwvzu6w
Working in the Granualtion Room